Find the Perfect Plan for Your Investment Journey
P
Latest price
52 Week Range
€0.65 - €0.97
Next Earnings Date
May 06 2025
Next Earnings Date
May 06 2025
Latest price
Market Cap | €503.37M |
EV | €449.69M |
Shares Outstanding | 683.93M |
Beta | 0.60 |
Analyst Rating | BUY |
Analyst Target Price | €1.90 |
P/E 2025E | - |
P/Revenue 2025E | 1.74x |
Revenue | 14.60% |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Revenue | 11.30% |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Gross Margin 2025E | 88.35% |
Net Profit Margin 2025E | -5.39% |
ROE 2025E | -5.10% |
ROCE 2024 | -5.38% |
DPS 2025E | - |
Payout Ratio 2025E | - |
Div. Yield 2025E | - |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
P
Pharming Group N.V.
PHARM
Sector
Healthcare
Industry
Biotechnology
CEO
de Vries, Sijmen
Employees
404
Website
www.pharming.comIPO Date
1999-06-16
Headquarters
Darwinweg 24, Leiden, Zuid-Holland, 2333 CR, Netherlands
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved